Advertisement

Topics

Guten Morgen mit Roche, ThyssenKrupp, Bechtle ...

03:22 EDT 10 May 2019 | FinanzNachrichten

ROG SE - Roche kündigt zahlreiche neue Daten für Krebskongress ASCO an NOVN SE - Novartis sieht Wirksamkeit von Gilenya bei MS durch neue Daten LHN SE - Cash: Zementkonzern - LafargeHolcim verkauft...

Original Article: Guten Morgen mit Roche, ThyssenKrupp, Bechtle ...

NEXT ARTICLE

More From BioPortfolio on "Guten Morgen mit Roche, ThyssenKrupp, Bechtle ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...